Deletion of 82–85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication
Author:
Gori Savellini Gianni1ORCID, Anichini Gabriele1ORCID, Manetti Fabrizio2ORCID, Trivisani Claudia Immacolata2ORCID, Cusi Maria Grazia1ORCID
Affiliation:
1. Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy 2. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy
Abstract
Non-structural protein 1 (Nsp1) represents one of the most crucial SARS-CoV-2 virulence factors by inhibiting the translation of host mRNAs and promoting their degradation. We selected naturally occurring virus lineages with specific Nsp1 deletions located at both the N- and C-terminus of the protein. Our data provide new insights into how Nsp1 coordinates these functions on host and viral mRNA recognition. Residues 82–85 in the N-terminal part of Nsp1 likely play a role in docking the 40S mRNA entry channel, preserving the inhibition of host gene expression without affecting cellular mRNA decay. Furthermore, this domain prevents viral mRNAs containing the 5′-leader sequence to escape translational repression. These findings support the presence of distinct domains within the Nsp1 protein that differentially modulate mRNA recognition, translation and turnover. These insights have implications for the development of drugs targeting viral proteins and provides new evidences of how specific mutations in SARS-CoV-2 Nsp1 could attenuate the virus.
Funder
Piano di Sostegno alla Ricerca (PSR) F-CUR 2022, University of Siena, Italy Italian Ministry of University and Research EU funding within the NextGenerationEU with Italian Ministry of University and Research Italian MIUR PNRR “One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases”
Reference53 articles.
1. World Health Organization (WHO) (2019, December 31). COVID-19 Dashboard. Available online: https://data.who.int/dashboards/covid19/deaths?n=c. 2. Activation and evasion of type I interferon responses by SARS-CoV-2;Lei;Nat. Commun.,2020 3. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses;Banerjee;Cell,2020 4. Shemesh, M., Aktepe, T.E., Deerain, J.M., McAuley, J.L., Audsley, M.D., David, C.T., Purcell, D.F.J., Urin, V., Hartmann, R., and Moseley, G.W. (2021). SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon. PLoS Pathog., 17. 5. Vazquez, C., Swanson, S.E., Negatu, S.G., Dittmar, M., Miller, J., Ramage, H.R., Cherry, S., and Jurado, K.A. (2021). SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS ONE, 16.
|
|